Clinical studies recruiting near Randwick

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Precision Medicine for Every Child With Cancer
Phase N/A · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Prince of Wales Hospital · Eli Lilly and Company · NCT07218380 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Sydney Children's Hospital · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Sydney Children's Hospital · National Cancer Institute (NCI) · NCT06172296 An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase 1/Phase 2 · Scientia Clinical Research · Pathios Therapeutics Pty Ltd · NCT06634849 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · Sydney Children's Hospital, Randwick · Relay Therapeutics, Inc. · NCT06789913 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Sydney Children's Hospital · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Sydney Children's Hospital · National Cancer Institute (NCI) · NCT05691478 A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Phase 1 · Scientia Clinical Research · Sun Pharma Advanced Research Company Limited · NCT07042100 BMB-101 in Absence Epilepsy and DEE
Phase 2 · The Prince of Wales Hospital · Bright Minds Biosciences Pty Ltd · NCT06401538 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Sydney Children's Hospital · Eli Lilly and Company · NCT07222332 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Sydney Children's Hospital Network - Randwick · Fore Biotherapeutics · NCT05503797 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Sydney Children's Hospital · Children's Oncology Group · NCT04322318 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Prince of Wales Hospital · Longboard Pharmaceuticals · NCT06660394 ROADMAP Clinical Trial
Phase 4 · Prince of Wales Hospital · University of Newcastle, Australia · NCT06771050 Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · Scientia Clinical Research · PYC Therapeutics · NCT06714006 Nectero EAST System Clinical Study
Phase 2/Phase 3 · Prince of Wales Private Hospital- POW Vascular Institute · Nectero Medical, Inc. · NCT06001918 Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor
Phase 2 · Prince of Wales Hospital-Medical Oncology ( Site 1601) · Merck Sharp & Dohme LLC · NCT04924075 To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab i
Phase 1/Phase 2 · Investigational site number #101 · Vir Biotechnology, Inc. · NCT05356741 Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
Phase 2/Phase 3 · The Bright Alliance · AMO Pharma Limited · NCT05004129 SNV4818 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · Scientia Clinical Research · Pikavation Therapeutics, Inc. · NCT06736704 High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris · NCT04221035 TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients
Phase 3 · Prince of Wales Hospital · University of Sydney · NCT06474273 A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Fried
Phase 3 · Sydney Children's Hospital · Biogen · NCT06953583 A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Phase 1/Phase 2 · Local Institution - 6104 · Turning Point Therapeutics, Inc. · NCT04094610 TITAN Trial: Reducing Phantom Limb Pain in People with Amputations
NA · Neuroscience Research Australia · Neuroscience Research Australia · NCT06167330 A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma
Phase 2 · Sydney Children's Hospital · Day One Biopharmaceuticals, Inc. · NCT04775485 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Sydney Children's Hospital · Children's Oncology Group · NCT04293562 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Prince of Wales Hospital-Randwick-66496 · Boehringer Ingelheim · NCT07472517 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557

Look up another city

Look up another condition